The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case
Background. Combination therapy with two antiplatelet agents (ticagrelor or clopidogrel plus acetylsalicylic acid) and a high dose statin is recommended in accordance with clinical guidelines for patients undergoing acute coronary syndrome and coronary intervention. Combined therapeutic regimens hav...
Saved in:
Main Authors: | O. V. Gaisenok (Author), Yu. M. Chichkov (Author), M. V. Leonova (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rosuvastatin-Induced reversible rhabdomyolysis
by: Sangeeta Pradhan, et al.
Published: (2023) -
Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
by: Keiki Sakurama, et al.
Published: (2023) -
Correction to: Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
by: Keiki Sakurama, et al.
Published: (2023) -
The problem of choice: original drug or generic? Emphasis on rosuvastatin
by: O. A. Polyakova, et al.
Published: (2022) -
A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions
by: Calderon-Ospina CA, et al.
Published: (2020)